A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs that are initially effective lose their potency over time, as malignant ...

Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...

The gene p53 acts as a tumor suppressor and often is called the ‘guardian of the genome.’ This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading ...

Gene that drops early in pancreatic tumors linked to shorter survival at stage II. Findings could guide future treatment ...

Genetic testing showed that childhood cancer survivors aged faster biologically, regardless of the treatment they received as ...

About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...

Cancer survival rates climbed significantly in recent decades. But federal funding cuts could threaten that progress, ...

The drug is not considered a cure, but results emerging from clinical trials point to the first major advancement in decades for a devastating cancer.